Lovelace Will be Attending ASGCT 2017
May 10-13
Washington, D.C.
May 10-13
American Society of Gene & Cell Therapy, Washington, D.C.
Lovelace Biomedical specializes in preclinical safety studies that help advance novel gene therapies to testing in human clinical trials. Visit us at Booth #305.
Lovelace will be attending the American Thoracic Society International Conference in Washington D.C.
May 19-24
Washington, D.C.
May 19-24
American Thoracic Society International Conference, Washington D.C.
A world leader in conducting pulmonary and respiratory disease research for more than 60 years, Lovelace Biomedical will be presenting at ATS 2017. The presentation is titled "Inhibition of Lung Fibrosis by INS1009, an Inhaled Prodrug Hexadecyl-Treprostinil Formulated in a Lipid Nanoparticle, Administered Therapeutically in Rats."
Lovelace will be attending the NorCal SOT, 2017
March 10, 2015, at 12pm
San Francisco Bay Area, CA
May 16
NorCal SOT, Pharmaceutical and Bioscience Society, San Francisco Bay Area
We will be exhibiting at NorCal SOT’s May 16 symposium, “Combination Therapy: Fundamentals, Advances, and Case Studies.” Don’t miss it!
